August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Oscar Tahuahua: Emotional Distress and Response to TIL Therapy In Phase III Melanoma Trial
Jul 14, 2025, 10:07

Oscar Tahuahua: Emotional Distress and Response to TIL Therapy In Phase III Melanoma Trial

Oscar Tahuahua, Medical Oncology Fellow at National Cancer Institute(Mexico), shared a post on X:

“Post-hoc Ph3 trial Pretreatment Emotional Distress in adv. Melanoma was linked to lower ORR with TIL Tx (37% vs 69%) & 2y PFS (16% vs 35%). A modifiable factor that may reduce immunotherapy efficacy, underscoring the stress-immune-cancer axis.”

Read the full article here.

Oscar Tahuahua: Emotional Distress and Response to TIL Therapy In Phase III Melanoma Trial

More about Immunotherapy for Melanoma on OncoDaily.